| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.03 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |